International Pharmacopsychiatry
August 11, 2017
Stanislav Grof, Robert A. Soskin, W.a. Richards et al.
35 citations
The usefulness of dipropyltryptamine (DPT) as an adjunct to psychedelic therapy was explored in a pilot study carried out on 51 alcoholic patients from the Alcoholic Rehabilitation Unit at Spring Grove State Hospital. The evaluation of the results was based on the comparison of pre- and posttreatment results of a battery of psychological tests and of pretreatment and follow-up ratings of an...
International Pharmacopsychiatry
August 11, 2017
J.M. Brewster, Ronald K. Siegel, C.A. Johnson et al.
An objective behavioral profile that was previously shown to distinguish the effects of hallucinogens from those of other classes of drugs was used here to further study hallucinogenic behaviors. Saline, d-amphetamine sulfate and five doses of dimethyltryptamine (DMT) were administered to solitary adolescent rhesus monkeys in a totally dark environment and their behavior was observed via...
International Pharmacopsychiatry
1973
Stanislav Grof, Louis E. Goodman, William A. Richards et al.
212 citations
The paper describes the results of a clinical study exploring the potential of a complex psychotherapeutic program utilizing psychedelic compounds to alleviate the emotional and physical suffering of cancer patients. A total of 60 cancer patients participated in this experimental study. In 44 of these patients, LSD (200-500 p%per os) was administered as an adjunct to psychotherapy; in 19...
International Pharmacopsychiatry
1971
F.s Abuzzahab, B. J. Anderson
47 citations
A total of 31 investigations involving 1,105 patients, on the effect of LSD in the treatment of alcoholics are reviewed. There were 13 single large-dose studies without controls, 5 such studies with controls, 4 studies of multiple low-dose LSD without controls, 3 multiple low-dose studies with controls, and 6 miscellaneous investigations that did not fit any of these categories. Single doses...
International Pharmacopsychiatry
1971
R. Fischer, R.M. Hill
7 citations
It was found that ergotropic arousal-inducing drugs, such as psilocybin, a Ditran®-type 'glycolate' and D-amphetamine, significantly lower human spatial distortion thresholds, i.e. these drugs interfere with counter-adaptation to optical distortion, or the intention to see the world undistorted. The trophotropic arousal-inducing chlorpromazine®on the other hand promotes such counter-adaptation,...